University of Cambridge researchers just pulled off something big. They used artificial intelligence to design a "super-antigen" for a vaccine that targets a wide range of coronaviruses, including all Covid variants and animal viruses with pandemic potential.
How the AI Vaccine Works
Normally vaccines chase one virus strain and quickly go outdated as it mutates. This time, scientists fed known genetic codes from many coronaviruses into AI. The system created one super-antigen that trains the immune system to recognize the whole family, even if new threats jump from animals to humans.
Prof Jonathan Heeney said “we're always behind... what we're trying to do is get ahead of the curve.” He called it the first AI-designed antigen trialled in people and “amazing what we can do with it for the good of humanity.”
Early Results and Next Steps
Trials in 39 people showed the vaccine is safe, with modest immune responses. A larger study with around 200 participants is underway. Experts like Prof Saul Faust called the AI approach “really exciting” for future pandemics.
The team is already working on universal flu vaccines, bird flu protection, and options for Ebola-like viruses. Other leaders, including Prof Andy Pollard, see AI as a game changer that could speed up development and save lives.
